Barclays Downgrades Idera Pharmaceuticals (IDRA) to Equalweight
Tweet Send to a Friend
Barclays analyst Gena Wang downgraded Idera Pharmaceuticals (NASDAQ: IDRA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
